Antibiotic Resistance Monitoring & Reference Laboratory (ARMRL)
HPA Centre for Infections
61 Colindale Avenue
London NW9 5EQ
Email: armrl@hpa.org.uk
Tel: +44 (0)20 8327 6511
Fax: +44 (0)20 8327 6264
Director: Dr David Livermore
Deputy Director: Dr Neil Woodford
ARMRL is the national reference laboratory responsible for the detection and investigation of antibiotic resistance.
In its Antibiotic Resistance and Evaluation Unit (Unit Head, Dr Robert Hill), ARMRL tests referred isolates (listed below), principally those thought by the senders to have unusual resistances. Minimum inhibitory concentrations (MICs) of relevant antibiotics are determined for these isolates, and ARMRL advises on which agents may be appropriate therapy, and on any public health risk.
In its Resistance Mechanisms Monitoring Unit (Unit Head, Dr Neil Woodford), ARMRL offers molecular detection of the genetic determinants (outlined below) of certain key resistances.
Request Form R3 (PDF, 87 KB)
Request Form H2 (PDF, 88 KB)
Request Form H1 (PDF, 89 KB)
| Table. Key resistances for confirmation | |
|---|---|
|
Organism |
Resistance Phenotype |
| S. aureus | Any of: vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, daptomycin , tigecycline |
| Coagulase-negative staphylococci | Any of: vancomycin, linezolid, quinupristin/dalfopristin, daptomycin, tigecycline |
| JK coryneforms | Any of: vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin |
| S. pneumoniae | Any of: meropenem, vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, tigecycline, penicillin (MICs >4 mg/L), cefotaxime (MICs >2 mg/L) |
| Group A, B, C, G b-haemolytic streptococci | Any of: penicillin, vancomycin, teicoplanin, linezolid, quinupristin/dalfopristin, tigecycline |
| Enterococci | Both ampicillin and quinupristin/dalfopristin, linezolid, teicoplanin but not vancomycin, daptomycin (MICs >8 mg/L), tigecycline |
| Enterobacteriaceae (= Coliforms) including members of the genera Enterobacter, Escherichia, Citrobacter, Serratia, Proteus, Providencia, Klebsiella, Morganella, Salmonella #, Shigella # | Ertapenem, meropenem, doripenem, imipenem (except Proteus spp.). Also, for E. coli only, tigecycline |
| Acinetobacter spp. | Any of : meropenem, doripenem, imipenem, colistin |
| Pseudomonas aeruginosa | Colistin |
| H. influenzae | Any third-generation cephalosporin, or carbapenem |
| M. catarrhalis | Ciprofloxacin, any third-generation cephalosporin |
| N. meningitidis* | Any of: penicillin (high level), ciprofloxacin |
| N. gonorrhoeae ! | Any third-generation cephalosporin |
| Anaerobes in general @ | Metronidazole |
| Bacteroides @ | Any of: metronidazole, co-amoxyclav, carbapenems |
| C. difficile @ | Any of : metronidazole, vancomycin |
Key
Unless indicated above, confirmation of resistance should be by ARMRL. Exceptions:-
* Confirmation by HPA Meningococcal Reference Unit, Manchester.
!Send gonococci to the Sexually Transmitted Bacteria Reference Laboratory, CfI.
@ Confirmation by HPA Anaerobe Reference Unit, Cardiff.
# Send Salmonellae, Shigellae to Laboratory of Enteric Pathogens, CfI.
ARMRL Newsletter (Winter 2008/9) (PDF, 79 KB)